Effect of Systemic Immunomodulators on Incidence of Alopecia Areata: A Retrospective Cohort Study
ABSTRACT Background Alopecia areata (AA) is a chronic autoimmune hair loss disorder. Patients with primary autoimmune diseases commonly use systemic immunomodulators to manage disease and have an increased risk of developing AA. Systemic immunomodulators have diverse immunologic effects, but their impact on AA risk is not well understood. Objectives We
Angela Rose Liu +2 more
wiley +1 more source
Analysis of preoperative predictors for pouchitis after surgery for ulcerative colitis: A multicentre retrospective study of the clinical outcome of surgery for ulcerative colitis in Japan (COSUC study). [PDF]
Kasashima H +9 more
europepmc +1 more source
The risk of colorectal cancer in ulcerative colitis: a meta-analysis
J. Eaden, K. Abrams, J. Mayberry
semanticscholar +1 more source
Clinical Features and Therapeutic Outcomes in Pyoderma Gangrenosum: A Prospective Cohort Study
ABSTRACT Background Pyoderma gangrenosum (PG) is a rare neutrophilic dermatosis highly associated with systemic comorbidities. Accurate diagnosis and treatment remain challenging due to its rarity and clinical mimickers. Objectives To evaluate demographic, clinical features and treatment outcomes in patients referred with suspected PG at a tertiary ...
David Croitoru +13 more
wiley +1 more source
Sterile Nasal Septal Abscess in Ulcerative Colitis With Crypt Abscess‐Like Neutrophilic Infiltration
We report a rare case of sterile nasal septal abscess in a patient with ulcerative colitis. Histopathological analysis revealed crypt abscess‐like neutrophilic infiltration in the nasal mucosal glands, resembling a typical feature of ulcerative colitis.
Masakazu Murayama +3 more
wiley +1 more source
Current and Emerging Autoantibodies in Ulcerative Colitis. [PDF]
Mendieta-Escalante EA +2 more
europepmc +1 more source
Budesonide Extended-Release in Patients With Mild to Moderate Ulcerative Colitis.
Asher Kornbluth
openalex +1 more source
Antithrombin: Deficiency, Diversity, and the Future of Diagnostics
ABSTRACT Our healthcare system provides reactive sick‐care, treating patients after symptoms have appeared by prescription of generic and often suboptimal therapy. This strategy brings along high costs and high pressure which is not sustainable.
Mirjam Kruijt +2 more
wiley +1 more source

